COVID-19 in adult acute myeloid leukemia patients: a long-term follow-up study from the European Hematology Association survey (EPICOVIDEHA)
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00023736%3A_____%2F23%3A00013499" target="_blank" >RIV/00023736:_____/23:00013499 - isvavai.cz</a>
Alternative codes found
RIV/00216208:11140/23:10449630 RIV/65269705:_____/23:00078261 RIV/00179906:_____/23:10449630 RIV/00098892:_____/23:10157918 and 2 more
Result on the web
<a href="https://doi" target="_blank" >https://doi</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.3324/haematol.2022.280847" target="_blank" >10.3324/haematol.2022.280847</a>
Alternative languages
Result language
angličtina
Original language name
COVID-19 in adult acute myeloid leukemia patients: a long-term follow-up study from the European Hematology Association survey (EPICOVIDEHA)
Original language description
Patients with acute myeloid leukemia (AML) are at high risk of dying from coronavirus disease 2019 (COVID-19). The optimal management of AML patients with COVID-19 has not been established. Our multicenter study included 388 adult AML patients diagnosed with COVID-19 between February 2020 and October 2021. Overall survival in patients with a diagnosis of COVID-19 between January 2020 and August 2020 was significantly lower than that in patients diagnosed between September 2020 and February 2021 and between March 2021 and September 2021 (39.8% vs. 60% vs. 61.9%, respectively, P=0.006). COVID-19 in AML patients was associated with a high mortality rate and modifications of therapeutic algorithms. The best approach to improve survival was to delay AML treatment, whenever possible.
Czech name
—
Czech description
—
Classification
Type
J<sub>imp</sub> - Article in a specialist periodical, which is included in the Web of Science database
CEP classification
—
OECD FORD branch
30205 - Hematology
Result continuities
Project
—
Continuities
I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace
Others
Publication year
2023
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Name of the periodical
Haematologica
ISSN
0390-6078
e-ISSN
—
Volume of the periodical
108
Issue of the periodical within the volume
1
Country of publishing house
IT - ITALY
Number of pages
12
Pages from-to
22-33
UT code for WoS article
001020890400001
EID of the result in the Scopus database
2-s2.0-85136991749